The results of a recent study suggested that extracellular PRL enhanced NSCLC cell proliferation and promoted JAK2/STAT3 signaling activity through GHR, but not PRLR as previously reported in breast and prostate cancers.26 The gene discussed is JAK2; the disease is prostate carcinoma.